Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP515464.RATHp-QbsYzi9j3uAwR3KMo7j0tP3LYifLqTmj4ve7tTs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP515464.RATHp-QbsYzi9j3uAwR3KMo7j0tP3LYifLqTmj4ve7tTs130_assertion type Assertion NP515464.RATHp-QbsYzi9j3uAwR3KMo7j0tP3LYifLqTmj4ve7tTs130_head.
- NP515464.RATHp-QbsYzi9j3uAwR3KMo7j0tP3LYifLqTmj4ve7tTs130_assertion description "[Our findings offer preclinical proof-of-concept for IRS1/2 inhibitors as cancer therapeutics including PLX4032-resistant melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515464.RATHp-QbsYzi9j3uAwR3KMo7j0tP3LYifLqTmj4ve7tTs130_provenance.
- NP515464.RATHp-QbsYzi9j3uAwR3KMo7j0tP3LYifLqTmj4ve7tTs130_assertion evidence source_evidence_literature NP515464.RATHp-QbsYzi9j3uAwR3KMo7j0tP3LYifLqTmj4ve7tTs130_provenance.
- NP515464.RATHp-QbsYzi9j3uAwR3KMo7j0tP3LYifLqTmj4ve7tTs130_assertion SIO_000772 23651636 NP515464.RATHp-QbsYzi9j3uAwR3KMo7j0tP3LYifLqTmj4ve7tTs130_provenance.
- NP515464.RATHp-QbsYzi9j3uAwR3KMo7j0tP3LYifLqTmj4ve7tTs130_assertion wasDerivedFrom befree-20150227 NP515464.RATHp-QbsYzi9j3uAwR3KMo7j0tP3LYifLqTmj4ve7tTs130_provenance.
- NP515464.RATHp-QbsYzi9j3uAwR3KMo7j0tP3LYifLqTmj4ve7tTs130_assertion wasGeneratedBy ECO_0000203 NP515464.RATHp-QbsYzi9j3uAwR3KMo7j0tP3LYifLqTmj4ve7tTs130_provenance.